FSD Pharma (CSE:HUGE-OTCQB:FSDDF) Executive Co-Chairman and CEO Dr Raza Bokhari sat down with Steve Darling from Proactive Investors Vancouver to talk about FSD hitting a company milestone by receiving their cannabis sales license from Health Canada.
Dr Bokhari also told Proactive about their recent acquisition of Prismic Pharmaceuticals. That company is a US-based speciality R&D pharmaceutical company that is developing novel non-addictive prescription drugs with unique safety profiles with the goal of addressing the opioid crisis based on formulations utilizing micro-palmitoylethanolamide’s “entourage” effect on certain drugs impacting the endocannabinoid system.
source